His primary areas of investigation include Anesthesia, Hyperalgesia, Pharmacology, Neuroscience and Opioid. The study incorporates disciplines such as Receptor, Noxious stimulus and Cannabinoid receptor in addition to Pharmacology. His research investigates the connection between Cannabinoid receptor and topics such as Cannabinoid that intersect with problems in Cannabinoid receptor type 2.
His Neuroscience research is multidisciplinary, incorporating perspectives in Analgesic and Nociceptor. His research in Opioid intersects with topics in Opioid-induced hyperalgesia, Rostral ventromedial medulla and Nociception. His Nociception research includes themes of Morphine, Endocrinology and Spinal cord.
Todd W. Vanderah focuses on Pharmacology, Opioid, Nociception, Internal medicine and Agonist. His Pharmacology study combines topics in areas such as Receptor, Antagonist and Hyperalgesia. His research integrates issues of Analgesic and Cholecystokinin receptor in his study of Opioid.
As a member of one scientific family, Todd W. Vanderah mostly works in the field of Nociception, focusing on Dynorphin and, on occasion, Dynorphin A. His study looks at the relationship between Internal medicine and topics such as Endocrinology, which overlap with Dorsal root ganglion. His studies in Agonist integrate themes in fields like Cannabinoid and Stereochemistry.
Todd W. Vanderah spends much of his time researching Pharmacology, Neuropathic pain, Agonist, Chronic pain and Opioid. His work carried out in the field of Pharmacology brings together such families of science as Receptor, Hyperalgesia, Antagonist, Nociception and Substance P. His Neuropathic pain study is focused on Neuroscience in general.
His Agonist research includes elements of Analgesic, Cannabinoid and Stereochemistry. His studies deal with areas such as Adenosine, Central nervous system, Endogenous opioid and Bioinformatics as well as Chronic pain. Todd W. Vanderah combines subjects such as Morphine and Ventral tegmental area with his study of Opioid.
Todd W. Vanderah mainly investigates Pharmacology, Neuropathic pain, Chronic pain, Nociception and Neuroscience. Todd W. Vanderah is studying Analgesic, which is a component of Pharmacology. His study focuses on the intersection of Analgesic and fields such as Agonist with connections in the field of Cannabinoid.
His Neuropathic pain research incorporates elements of Threshold of pain and Nerve injury. Todd W. Vanderah has researched Nociception in several fields, including Sensory neuron and Dorsal root ganglion, Spinal cord. His Neuroscience research includes elements of Synaptic plasticity, Schizophrenia and Autism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Mohab M. Ibrahim;Frank Porreca;Josephine Lai;Phillip J. Albrecht.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
Mohab M. Ibrahim;Hongfeng Deng;Alexander Zvonok;Debra A. Cockayne.
Proceedings of the National Academy of Sciences of the United States of America (2003)
CB2 cannabinoid receptor-mediated peripheral antinociception.
T.Philip Malan;Mohab M. Ibrahim;Hongfeng Deng;Qian Liu.
Unmasking the tonic-aversive state in neuropathic pain.
Tamara King;Louis Vera-Portocarrero;Tannia Gutierrez;Todd W Vanderah.
Nature Neuroscience (2009)
Molecular Determinants of Vanilloid Sensitivity in TRPV1
Narender R. Gavva;Lana Klionsky;Yusheng Qu;Licheng Shi.
Journal of Biological Chemistry (2004)
AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties
Narender R. Gavva;Rami Tamir;Yusheng Qu;Lana Klionsky.
Journal of Pharmacology and Experimental Therapeutics (2005)
Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance
Todd W. Vanderah;Luis R. Gardell;Shannon E. Burgess;Mohab Ibrahim.
The Journal of Neuroscience (2000)
Distinct potassium channels on pain-sensing neurons
Matthew N. Rasband;Eunice W. Park;Todd W. Vanderah;Josephine Lai.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.
Shannon E. Burgess;Luis R. Gardell;Michael H. Ossipov;T. Philip Malan.
The Journal of Neuroscience (2002)
Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance
Todd W. Vanderah;Nova M. H. Suenaga;Michael H. Ossipov;T. Philip Malan.
The Journal of Neuroscience (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: